tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

TrivarX Extends Trading Suspension Amid Acquisition Plans

Story Highlights
TrivarX Extends Trading Suspension Amid Acquisition Plans

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An update from TrivarX Limited ( (AU:TRI) ) is now available.

TrivarX Limited has announced an extension of its voluntary trading suspension as it prepares to disclose details about a significant acquisition and potential capital raising. This move indicates strategic growth efforts and could have implications for the company’s market positioning and stakeholder interests.

More about TrivarX Limited

TrivarX Limited is a mental health technology company that focuses on pioneering the use of objective measures for early detection and screening of mental health conditions. Founded in Australia, the company operates with offices in Perth and Minneapolis and is listed on the Australian Securities Exchange and the OTCQB Venture Market.

YTD Price Performance: -31.25%

Average Trading Volume: 1,390,315

Technical Sentiment Signal: Strong Sell

Current Market Cap: A$6.82M

Learn more about TRI stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1